ZFP521 regulates murine hematopoietic stem cell function and facilitates MLL-AF9 leukemogenesis in mouse and human cells
- PMID: 28615219
- PMCID: PMC5542850
- DOI: 10.1182/blood-2016-09-738591
ZFP521 regulates murine hematopoietic stem cell function and facilitates MLL-AF9 leukemogenesis in mouse and human cells
Abstract
The concept that tumor-initiating cells can co-opt the self-renewal program of endogenous stem cells as a means of enforcing their unlimited proliferative potential is widely accepted, yet identification of specific factors that regulate self-renewal of normal and cancer stem cells remains limited. Using a comparative transcriptomic approach, we identify ZNF521/Zfp521 as a conserved hematopoietic stem cell (HSC)-enriched transcription factor in human and murine hematopoiesis whose function in HSC biology remains elusive. Competitive serial transplantation assays using Zfp521-deficient mice revealed that ZFP521 regulates HSC self-renewal and differentiation. In contrast, ectopic expression of ZFP521 in HSCs led to a robust maintenance of progenitor activity in vitro. Transcriptional analysis of human acute myeloid leukemia (AML) patient samples revealed that ZNF521 is highly and specifically upregulated in AMLs with MLL translocations. Using an MLL-AF9 murine leukemia model and serial transplantation studies, we show that ZFP521 is not required for leukemogenesis, although its absence leads to a significant delay in leukemia onset. Furthermore, knockdown of ZNF521 reduced proliferation in human leukemia cell lines possessing MLL-AF9 translocations. Taken together, these results identify ZNF521/ZFP521 as a critical regulator of HSC function, which facilitates MLL-AF9-mediated leukemic disease in mice.
Conflict of interest statement
Conflict-of-interest disclosure: The authors declare no competing financial interests.
Figures
Similar articles
-
Exploring the contribution of Zfp521/ZNF521 on primary hematopoietic stem/progenitor cells and leukemia progression.Cell Tissue Res. 2024 Dec;398(3):161-173. doi: 10.1007/s00441-024-03926-2. Epub 2024 Oct 22. Cell Tissue Res. 2024. PMID: 39436449 Free PMC article. Review.
-
ZNF521 Enhances MLL-AF9-Dependent Hematopoietic Stem Cell Transformation in Acute Myeloid Leukemias by Altering the Gene Expression Landscape.Int J Mol Sci. 2021 Oct 6;22(19):10814. doi: 10.3390/ijms221910814. Int J Mol Sci. 2021. PMID: 34639154 Free PMC article.
-
ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia.Oncotarget. 2017 Apr 18;8(16):26129-26141. doi: 10.18632/oncotarget.15387. Oncotarget. 2017. PMID: 28412727 Free PMC article.
-
Tet1 is not required for myeloid leukemogenesis by MLL-ENL in novel mouse models.PLoS One. 2021 Mar 11;16(3):e0248425. doi: 10.1371/journal.pone.0248425. eCollection 2021. PLoS One. 2021. PMID: 33705482 Free PMC article.
-
Leukemogenesis via aberrant self-renewal by the MLL/AEP-mediated transcriptional activation system.Cancer Sci. 2021 Oct;112(10):3935-3944. doi: 10.1111/cas.15054. Epub 2021 Aug 2. Cancer Sci. 2021. PMID: 34251718 Free PMC article. Review.
Cited by
-
Exploring the contribution of Zfp521/ZNF521 on primary hematopoietic stem/progenitor cells and leukemia progression.Cell Tissue Res. 2024 Dec;398(3):161-173. doi: 10.1007/s00441-024-03926-2. Epub 2024 Oct 22. Cell Tissue Res. 2024. PMID: 39436449 Free PMC article. Review.
-
ZNF521 Is Correlated with Tumor Immune Cell Infiltration and Act as a Valuable Prognostic Biomarker in Gastric Cancer.Gastroenterol Res Pract. 2022 Oct 19;2022:5288075. doi: 10.1155/2022/5288075. eCollection 2022. Gastroenterol Res Pract. 2022. PMID: 36311294 Free PMC article.
-
Zinc Finger Protein 521 Regulates Early Hematopoiesis through Cell-Extrinsic Mechanisms in the Bone Marrow Microenvironment.Mol Cell Biol. 2018 Aug 15;38(17):e00603-17. doi: 10.1128/MCB.00603-17. Print 2018 Sep 1. Mol Cell Biol. 2018. PMID: 29915154 Free PMC article.
-
The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia.Leukemia. 2019 Dec;33(12):2830-2841. doi: 10.1038/s41375-019-0505-x. Epub 2019 Jun 10. Leukemia. 2019. PMID: 31182782
-
Biological and therapeutic implications of a unique subtype of NPM1 mutated AML.Nat Commun. 2021 Feb 16;12(1):1054. doi: 10.1038/s41467-021-21233-0. Nat Commun. 2021. PMID: 33594052 Free PMC article.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases